The association between low-level viraemia and subsequent viral non-suppression among people living with HIV/AIDS on antiretroviral therapy in Uganda.

Nicholus NanyeenyaLarry William ChangNoah KiwanukaEsther NasuunaDamalie NakanjakoGertrude NakigoziSimon Peter Sebina KibiraSusan NabaddaCharles KiyagaFredrick Makumbi

Published in: PloS one (2023)

Our study indicated that PLHIV with LLV increased from 2.0% in 2016 to 8.6% in 2020, and PLHIV with LLV had 4.1 times the hazard rate of developing viral non-suppression, as compared to PLHIV with a non-detectable VL. Hence the need to review the VL testing algorithm and also manage LLV in Uganda.

Keyphrases

hiv aids
antiretroviral therapy
hiv infected
human immunodeficiency virus
sars cov
hiv infected patients
hiv positive
hepatitis c virus